Cancer BiologyAmerican Journal of Cancer ResearchPeer-reviewed
Synergistic combination therapy with ONC201 or ONC206, Enzalutamide and Darolutamide in preclinical studies of castration-resistant prostate cancer
Laura Jinxuan Wu, Maximilian P. Pinho-Schwermann, Lanlan Zhou…·Wafik S. El‐Deiry
This study shows that combining ONC201 with enzalutamide or darolutamide synergistically reduces mCRPC cell viability and PSA levels, with in vivo anti-tumor effects.
7 citations